Lacerta Therapeutics

news

Founded in 2017, Lacerta has just opened a brand-new R&D laboratory facility custom built to our specifications in the heart of Alachua, Florida.

LACERTA THERAPEUTICS FEATURED AT ALACHUA CHAMBER LUNCH

We want to thank the Alachua Chamber of Commerce for featuring us at the Alachua Chamber Lunch on August 3rd, 2021 at the Alachua Woman’s …

Read More →

UCB strengthens its gene therapy activities with additional pipeline programs, capabilities and platforms

BRUSSELS, Nov. 12, 2020 /PRNewswire/ — UCB today announced the acquisition of Handl Therapeutics BV, a rapidly growing and transformative gene therapy company based in Leuven, Belgium and a new …

Read More →

Lacerta Therapeutics Signs Gene Therapy Research Partnership with UCB

New research collaboration and licensing agreement with Lacerta provides UCB access to a novel gene therapy program and proprietary AAV capsids ALACHUA, Fla., November 12, …

Read More →

Concept Companies Unveils New Office for Lacerta Therapeutics in Alachua’s Copeland Park

Link to article ALACHUA, Fla., Oct. 8, 2020 /PRNewswire/ — Gainesville-based developer Concept Companies has completed construction on a new 12,950-square-foot office and lab building in Copeland Park …

Read More →

Gene therapy startup Lacerta Therapeutics raises $30M in equity financing from Sarepta

Sarepta Therapeutics gains rights to University of Florida-resident startup’s programs for central nervous system diseases. By Alaric DeArment August 14, 2018  – A startup based out …

Read More →

UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round

GAINESVILLE, Fla.–(BUSINESS WIRE)–UF Innovate | Sid Martin Biotech, the leading biotechnology incubator at the University of Florida, announces resident company Lacerta Therapeutics, Inc., has closed on …

Read More →

Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics

Press Release August 8, 2018 at 4:01 PM EDT Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics, Gaining Rights to Multiple …

Read More →